These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30976097)

  • 1. CRISPR in the North American popular press.
    Marcon A; Master Z; Ravitsky V; Caulfield T
    Genet Med; 2019 Oct; 21(10):2184-2189. PubMed ID: 30976097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR off-targets: a question of context.
    Haeussler M
    Cell Biol Toxicol; 2020 Feb; 36(1):5-9. PubMed ID: 31734746
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Playing God? Media coverage of CRISPR in the United States.
    Stapleton P; Torres Yabar A
    Public Underst Sci; 2023 May; 32(4):504-521. PubMed ID: 36527362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR: express delivery to any DNA address.
    Peterson A
    Oral Dis; 2017 Jan; 23(1):5-11. PubMed ID: 27040868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
    Locke LG
    CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of CRISPR/Cas9 in Crop Quality Improvement.
    Liu Q; Yang F; Zhang J; Liu H; Rahman S; Islam S; Ma W; She M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 14. A Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape.
    Zhou W; Yuan Y; Zhang Y; Chen D
    CRISPR J; 2021 Jun; 4(3):313-320. PubMed ID: 34152220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontiers in CRISPR.
    Weidmann AG
    ACS Chem Biol; 2018 Feb; 13(2):296-304. PubMed ID: 29448764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking CRISPR's Footprints.
    Lin L; Luo Y
    Methods Mol Biol; 2019; 1961():13-28. PubMed ID: 30912037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After the fact-the case of CRISPR babies.
    Sand M; Bredenoord AL; Jongsma KR
    Eur J Hum Genet; 2019 Nov; 27(11):1621-1624. PubMed ID: 31235868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box.
    Karlgren M; Simoff I; Keiser M; Oswald S; Artursson P
    Drug Metab Dispos; 2018 Nov; 46(11):1776-1786. PubMed ID: 30126863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.
    Zhang D; Hussain A; Manghwar H; Xie K; Xie S; Zhao S; Larkin RM; Qing P; Jin S; Ding F
    Plant Biotechnol J; 2020 Aug; 18(8):1651-1669. PubMed ID: 32271968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.